Activated Akt1 Speeds Up Breast Cancer Development in Mice
Author Information
Author(s): Christian D Young, Erica C Nolte, Andrew Lewis, Natalie J Serkova, Steven M Anderson
Primary Institution: University of Colorado Denver
Hypothesis
Can activated Akt1 accelerate mammary tumorigenesis in MMTV-c-ErbB2 mice?
Conclusion
Activated Akt1 expression in MMTV-c-ErbB2 mice leads to faster tumor development and alters signaling pathways critical for tumorigenesis.
Supporting Evidence
- Bitransgenic mice developed tumors twice as fast as MMTV-c-ErbB2 mice.
- Bitransgenic tumors showed less organized structure and higher mitotic figures.
- Bitransgenic tumors had a higher rate of glucose transporter expression and lactate production.
Takeaway
When a special protein called Akt1 is turned on in mice with a certain type of breast cancer, the cancer grows much faster. This might help us understand why some treatments don't work.
Methodology
The study involved crossing two types of transgenic mice and monitoring tumor development through palpation and histological analysis.
Potential Biases
Potential bias in interpreting the effects of Akt1 activation due to reliance on specific mouse models.
Limitations
The study is limited to mouse models and may not fully represent human breast cancer biology.
Participant Demographics
Female mice of the MMTV-c-ErbB2 and MMTV-myr-Akt1 strains.
Statistical Information
P-Value
p<0.00001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website